David E. Martin
Amministratore Delegato presso TrippBio, Inc.
Profilo
David E.
Martin is currently the President & Chief Executive Officer at TrippBio, Inc. He previously worked as the Associate Director-Clinical Pharmacology at Bristol Myers Squibb Co. and as the Assistant Director-Virology Clinical Development at PharmaResearch Corp.
He also served as the Senior Vice President-Drug Development at Panacos Pharmaceuticals, Inc. and as the Senior VP-Drug Development & Regulatory Affairs at Tobira Therapeutics, Inc. Dr. Martin holds an MBA from St. Joseph's University and a doctorate from USC School of Pharmacy.
Posizioni attive di David E. Martin
| Società | Posizione | Inizio |
|---|---|---|
TrippBio, Inc.
 TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL. | Amministratore Delegato | 25/05/2021 |
Precedenti posizioni note di David E. Martin
| Società | Posizione | Fine |
|---|---|---|
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Corporate Officer/Principal | 01/03/2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2001 |
PharmaResearch Corp
 PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | Corporate Officer/Principal | 01/01/1999 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Consigliere Generale | - |
| PANACOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di David E. Martin
| St. Joseph's University | Masters Business Admin |
| USC School of Pharmacy | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
PharmaResearch Corp
PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | Commercial Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
TrippBio, Inc.
TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL. | Commercial Services |
- Borsa valori
- Insiders
- David E. Martin
